Navigation Links
Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin
Date:12/7/2007

DALLAS, Dec. 7 /PRNewswire-FirstCall/ -- Access Pharmaceuticals, Inc. (OTC Bulletin Board: ACCP) announced today that it has demonstrated the ability, using the company's proprietary Cobalamin(TM) technology, to significantly reduce glucose levels in an animal model of diabetes, through its oral insulin product candidate. Several formulations using Cobalamin, which is based upon the body's natural absorption of vitamin B12 in the gastrointestinal tract, were tested in an animal model of diabetes. Additional pre-clinical studies are planned.

Access has patents and formulations based on vitamin B12 attachment to polymers and nanoparticles which carry an attached or encapsulated drug. The vitamin B12 absorption mechanism transfers the macrostructure from the gut to blood, facilitating the absorption of drugs that otherwise could not be delivered orally. Access' Cobalamin(TM) technology has the potential to enable and improve oral bioavailability of active drugs which currently have to be administered by injection, including proteins, antibodies and siRNA.

"While Access already has proof-of-principle data using this technology with a variety of proteins and peptides, we are delighted to have attained preclinical study results which indicate that a meaningful pharmacological effect can be achieved," stated Dr. David P. Nowotnik, Access' Senior Vice President, Research and Development. "As a result of this very promising result, we plan to complete a short series of formulation optimization studies and then to select a clinical development candidate."

Access intends to develop the Cobalamin(TM) oral delivery technology in collaboration with other pharmaceutical and biotechnology companies. Access has in the past and continues to conduct sponsored research programs with leading pharmaceutical companies based on its Cobalamin technology. The company is also actively seeking additional partners for both its oral insulin and other potential program
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
2. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
3. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
4. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
5. Access Pharmaceuticals to Present Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
6. Access Pharmaceuticals Announces Two Poster Presentations Reporting Significant Preclinical Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
7. Demand for Spanish-Language Cancer Web Materials Quadruples; Internet Resources and Access Remain Scarce
8. New Analysis from 14 Countries Identifies Drug Access Priorities to Achieve 2010 AIDS Treatment Target
9. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
10. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
11. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... , Aug. 28, 2015 ... has announced the addition of the "Investigation ... to their offering. Originally discovered by ... Yoshitomi Pharmaceutical Industries, Ltd) as an inflammatory drug, ... Senju Pharmaceutical Co., Ltd under the trade name ...
(Date:8/28/2015)... Aug. 28, 2015  Today, in final recognition of ... Lens Health Week, 1-800 Contacts is sharing how to ... contact lens wearers who do not properly care for ... eye infections. Most contact lens wearers ... a clean lens case is sometimes overlooked.  When proper ...
(Date:8/28/2015)... , Aug. 28, 2015 ... has announced the addition of the "Investigation ... to their offering. Developed by Pharmacia ... prostaglandin receptor agonist which effectively reduces intraocular pressure. ... FDA, latanoprost (under the trade name of Xalatan) ...
Breaking Medicine Technology:Investigation Report on China's Pranoprofen Market, 2010-2019 21-800 Contacts Shares Tips on How to Clean Lens Cases 2China Latanoprost Market Investigation Report 2015-2019 2
... PALO ALTO, Calif. , April 28 Jazz Pharmaceuticals, Inc. (Nasdaq: ... financial results on Wednesday, May 5, 2010 .  Jazz Pharmaceuticals will host ... well as to discuss financial results and guidance, on May 5, 2010 ... , , , ...
... April 28 The biopharma mega-mergers that grabbed headlines last year ... are now in the critical post-integration period and the acquiring companies are ... too early for final verdicts, but clearly one M&A issue that continues ... , , , ...
Cached Medicine Technology:Jazz Pharmaceuticals to Announce First Quarter 2010 Financial Results on May 5, 2010 2Bio-Pharma Industry Experts Deliver M&A Value Through Integration Excellence 2Bio-Pharma Industry Experts Deliver M&A Value Through Integration Excellence 3
(Date:8/31/2015)... ... August 31, 2015 , ... The more hours young adults spend watching television ... and bigger waist circumference, a 15-year analysis by the University of Pittsburgh Graduate School ... years, indicating that young adulthood is an important time to intervene and promote less ...
(Date:8/31/2015)... ... August 31, 2015 , ... With baseball season in full swing, many fans ... dominate the sports world. Fans desire nothing more than to see their favorite team ... children, especially those who are too young to really understand what all the fuss ...
(Date:8/31/2015)... ... August 31, 2015 , ... Castle Dermatology Institute now welcomes ... Ghasri is a graduate of the University of California, Los Angeles. He graduated summa ... the University of California, Irvine Medical School. As a nationally recognized Regents Scholar, Dr. ...
(Date:8/31/2015)... , ... August 31, 2015 , ... ... Month 2015 in September by sharing the facts about the role of heredity ... and BRCA2 genetic mutations because of Angelina Jolie Pitt’s decisions to have both ...
(Date:8/31/2015)... ... 31, 2015 , ... In preparation for this November’s National Family Caregivers Month, ... sound amplifier, is offering caregivers “7 Reasons to Care about Hearing Health.” The information ... a variety of home healthcare challenges, specifically as they relate to caring for the ...
Breaking Medicine News(10 mins):Health News:Watching More TV as a Young Adult Predicts Obesity 2Health News:Watching More TV as a Young Adult Predicts Obesity 3Health News:New Children's Baseball Series Offers Young Fans a Way to Celebrate the World Series 2Health News:Castle Dermatology Institute Now Welcomes Dr. Pedram Ghasri to the Practice 2Health News:Foundation for Women’s Cancer Alerts Women to the Facts About the Role of Heredity in Gynecologic Cancers 2Health News:Foundation for Women’s Cancer Alerts Women to the Facts About the Role of Heredity in Gynecologic Cancers 3Health News:Foundation for Women’s Cancer Alerts Women to the Facts About the Role of Heredity in Gynecologic Cancers 4Health News:Etymotic Offers Caregivers “7 Reasons to Care about Hearing Health” 2Health News:Etymotic Offers Caregivers “7 Reasons to Care about Hearing Health” 3
... nation is once again readying itself for losing an hour ... This is a shock not only to those of us ... levels of the economy, from the individual to the world. ... Economics, Cues for Timing and Coordination: Latitude, Letterman, and Longitude, ...
... Statement from Chuck,Mohan, executive director and ... reports of possible links between childhood vaccinations ... studies documenting that childhood,vaccinations cause or worsen ... research in this area. Mitochondrial diseases are ...
... Program Offers Millions in Potential Savings, DALLAS, ... millions of dollars annually through an innovative,initiative of ... and RxHub,LLC. The proprietary program helps ACS, healthcare ... commercial insurers., The new program enables pharmacies ...
... factor for knee repair surgery, study suggests , , THURSDAY, ... active on the basketball court and soccer field, and ... surgery just as easily as their younger counterparts. , ... women in their 50s and 60s did well after ...
... Donates Proceeds to Rainforest Foundation and Promotes Natural Cancer ... ... Under the Canopy(R), the,premier organic lifestyle brand, launches its cutting edge 2008 ... of Luxury Home Fashion Collection at Natural Products Expo West, Under ...
... No. 1 Among Health Care: Pharmacy and Other Services; No. 1 ... ... No. 3 for Innovation, FRANKLIN LAKES, N.J., March 6 ... position within the Health,Care: Pharmacy and Other Services sector on Fortune,s ...
Cached Medicine News:Health News:Early to bed early to rise ... depends on the TV schedule in your time zone 2Health News:Early to bed early to rise ... depends on the TV schedule in your time zone 3Health News:ACS Launches Medicaid Cost Savings Initiative 2Health News:ACS Launches Medicaid Cost Savings Initiative 3Health News:ACL Tears Worth Fixing in Seniors 2Health News:Under the Canopy(R) Turns a New Leaf With 2008 Spring Season 2Health News:Medco Tops Fortune's List of 'America's Most Admired' Companies in its Industry 2Health News:Medco Tops Fortune's List of 'America's Most Admired' Companies in its Industry 3
... sensitivity chart test face is the most widely ... test provides for four (4) rows of sine-wave ... ft (2.5 meters), these gratings test the spatial ... The CSV-1000E provides a full contrast sensitivity curve, ...
Contrast sensitivity testing, glare sensitivity testing and ETDRS acuity testing are provided in the self standardized CSV-1000 instrument. Patented photocell circuitry automatically monitors and cal...
The first book to translate key medical data into clear guidelines capturing the highest treatment standards for heart disease....
... Cochrane Reviews enable all those involved ... date with the very latest evidence in ... which becomes harder each year as the ... this problem by delivering the best single ...
Medicine Products: